Followers | 24 |
Posts | 1083 |
Boards Moderated | 0 |
Alias Born | 06/15/2015 |
Friday, September 20, 2019 1:22:40 PM
Setting aside the 3 or 4 $evio CFO's that either quit or were fired in 2017/18 and the auditors that were fired in Feb 2019 - obviously all losers who were not up to the exceedingly high professional standards set by $evio CEO Will Wally Droopy - The narrative being circulated was something something "11 different quickens consolidated into one software delivering data streamlined to timely filings" -
So it took 8 1/2 months to get the 2018 10k out - The management team had 8 1/2 months to figure out the problems in their systems, right?
Now its 5 weeks since that release and we havent seen the 2019 10Q-1!!!
How is that even possible?!?! Everything is stream lined? Youve learned along the way how to do it, what the auditors, regulators want, RIGHT?
You have a delinquency signage on your stock? The market is attacking your share price at will swinging it 10-20-30% at a time on low volume.
Your ability to raise capital has been extinguished. Apparently your STOP sign Delinquency status is affecting your ability to open and operate the Massachussetts Lab thats burning at least $25,000 a month in overhead?
And yet still, $EVIO management has learned nothing from the experience to get a simple 10Q out?!
WOuld anyone from the company or anyone from the adoring masses on this board of "everything is awesome, this is a long term play, bruh! stop hating, yo" crowd care to explain in a manner affixed firmly in reality how any of this is acceptable, or even possible to accomplish?!
How failing this spectacularly at such a simple task is either a sign of a management team purposely tanking the company or one led by someone with a mental illness and lack of ability, living in a fantasy world and holding shareholders hostage to his delusions of grandeur?
If you read the 10K closely youd see that the division of power is structured that EVIO corporate doesnt have much to do. The labs operate themselves. Since $EVIO has neglected to set up a biotech or research division the only tasks they appear to have are to secure capital and equipment as necessary, look for acquisitions etc. And file their quarterlies. What the actual frick
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM